The results are published in an article in The Lancet Neurology. He is professor of neurochemistry and head of the Department of Psychiatry and Neurochemistry at the Sahlgrenska Academy, senior consultant in clinical chemistry at the Sahlgrenska University Hospital, guest professor of neurochemistry at University College London and a Wallenberg Academy Fellow. Get the latest news and updates from the Foundation directly to your inbox. Professor Henrik Zetterberg at the University of Gothenburg will head a major European research collaboration, which is… News – 31 August 2017 New possibility of studying how Alzheimer's disease affects the brain at… Professor of Neurochemistry, Senior Consultant in Clinical Chemistry, Head of Department Place of work / study: The Sahlgrenska Academy at the University of Gothenburg, … With a background in molecular biology and clinical chemistry, Henrik Zetterberg, MD, PhD, has spent the last 10 years focusing on the development of biomarkers for Alzheimer’s disease, Parkinson’s disease and other brain disorders. Henrik Zetterberg’s steady outlook on life could date back to his tranquil upbringing close to the Gothenburg archipelago . Dr. Zetterberg is a professor of neurochemistry at the University of Gothenburg, Sweden and at University College London, UK, as well as the head of the Sahlgrenska Academy Department of Psychiatry and Neurochemistry at the University of Gothenburg, Sweden. Henrik Zetterberg is a professor and physician, as well as head of the Department of Psychiatry and Neurochemistry at the University of Gothenburg. While usually broken down and eliminated under healthy conditions, in patients with the disease, fragments of the protein amyloid beta (Aβ) clump together to form plaques. He researches biomarkers in brain diseases and in this video he talks about the research advances in recent years when it comes to detecting and treating Alzheimer's disease. Henrik Zetterberg is a Professor of Neurochemistry and has a research background in molecular biology and clinical chemistry. Join us as we work to find a cure for the 6 million people worldwide living with Parkinson's. Henrik Zetterberg, Professor at the University of Gothenburg, shares his expertise on fluid and blood-based biomarkers and the impact these types of biomarkers will have on the future of neurodegenerative drug development. Professor of Neurochemistry, UCL, 2012 Research Summary With a background in molecular biology and medicine, I have spent the last 10 years developing biomarkers for … Scientists believe this is a central event leading to the death of neurons, but there have been disappointing results from clinical trials that have attempted to target the disease mechanism. The results are published in an article in The Lancet Neurology. Henrik Zetterberg is a Professor of Neurochemistry at the University of Gothenburg, Sweden, and University College London (UCL), UK, and a Clinical Chemist at the Sahlgrenska University Hospital in … With a background in molecular biology and medicine, I have spent the last 10 years developing biomarkers for Alzheimer's disease and other brain disorders. At the same time, autopsies have shown that some people who have never shown signs of Alzheimer’s disease have nonetheless had plaque in the brain. Today, he is Professor of Neurochemistry, Henrik Zetterberg is professor of neurochemistry at the University of Gothenburg and chief physician in clinical chemistry at Sahlgrenska University Hospital. He is Head of the Department of Psychiatry and Neurochemistry at the University of Gothenburg, and his main research focus and clinical interest is fluid biomarkers for central nervous system diseases. Whether it’s the virus or the immune system that’s causing this is unclear at present and more research is needed,” said Henrik Zetterberg, Professor of Neurochemistry, whose research team performed the measurements. https://sv.wikipedia.org/wiki/Henrik_Zetterberg_(professor) Henrik Zetterberg, MD, PhD Professor of Neurochemistry, Senior Consultant in Clinical Chemistry Henrik Zetterberg is a Professor of Neurochemistry at the University of Gothenburg, Sweden, and University College London, UK, and a Clinical Chemist at the Sahlgrenska University Hospital in Gothenburg. I am a researcher, clinician or work with the PD community. His parents inspired his love of nature, which would eventually translate into a love of science and a medical degree. Prof Henrik Zetterberg Professor of Neurochemistry Neurodegenerative Diseases UCL Queen Square Institute of Neurology Joined UCL 1st Apr 2012. Henrik Zetterberg is a professor of neurochemistry, who was trained at the University of Gothenburg in Sweden, and then completed a postdoc in Boston at the Center for Neurologic Diseases. This ha… Dr. Henrik Zetterberg Professor of Neurochemistry and Head of the Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg. Henrik Zetterberg is a Professor of Neurochemistry at the University of Gothenburg, Sweden, and University College London, UK, and a Clinical Chemist at Sahlgrenska University Hospital in Gothenburg, Sweden. Henrik Zetterberg is a Professor of Neurochemistry at the University of Gothenburg, Sweden, and University College London, UK, and a Clinical Chemist at the Sahlgrenska University Hospital in Gothenburg. With a background in molecular biology and clinical chemistry, Henrik Zetterberg, MD, PhD, has spent the last 10 years focusing on the development of biomarkers for Alzheimer’s disease, Parkinson’s disease and other brain disorders. Henrik Zetterberg, Gustav Nyquist and Anthony Mantha, Detroit Red Wings, December 20, 2017 (Amy Irvin / The Hockey Writers) Where Zetterberg really cemented his … Whether it’s the virus or the immune system that’s causing this is unclear at present, and more research is needed,” says Henrik Zetterberg, Professor of Neurochemistry, whose research team at Sahlgrenska Academy performed the measurements. JavaScript is currently disabled. This way, Professor Henrik Zetterberg and his colleagues could show that a special nerve cell protein, called tau, at elevated levels in the blood is a marker of concussion. Research summary. Dr. Andrew Nixon, PhD Associate Professor in Medicine, Member of the Duke Cancer Institute. We advance knowledge, education, and models of care for people affected by critical illness. Dr. Zetterberg has received numerous prizes, including the Erik K. Fernström Prize for Junior Scientists and the Inga Sandeborg Prize for Research on Alzheimer’s Disease. Download (PPT) Henrik Zetterberg's steady outlook on life could date back to his tranquil upbringing close to the Gothenburg archipelago in Sweden. IMAGE: Henrik Zetterberg, Professor of Neurochemistry, and Magnus Gisslén, Professor of Infectious Diseases, Sahlgrenska Academy, University of Gothenburg.view more . By continuing to use this website, you indicate that you have read our. Research summary. in Sweden. Dr. Henrik Zetterberg is a professor of neurochemistry at the University of Gothenburg, Sweden and at University College London, UK, as well as the head of the department of psychiatry and neurochemistry at the Sahlgrenska Academy at the University of Gothenburg, Sweden. The research behind the test was headed by Kaj Blennow, Professor of Clinical Neurochemistry, and Henrik Zetterberg, Professor of Neurochemistry, at Sahlgrenska Academy, University of Gothenburg. Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube. Critical Illness, Brain Dysfunction, and Survivorship (CIBS) Center | Suite 450, 4th Floor, 2525 West End Avenue | Nashville, TN 37203. Search for topics, articles, videos, research, etc... We use cookies to ensure that you get the best experience. The protein clumps decrease, but the disease worsens nonetheless,” says Henrik Zetterberg who is Chief Physician at Sahlgrenska University Hospital and Professor at the University of Gothenburg. Prof Henrik Zetterberg Professor of Neurochemistry Neurodegenerative Diseases UCL Queen Square Institute of Neurology Joined UCL 1st Apr 2012. Developing early tests for dementia One of the hallmarks of Alzheimer’s disease is the build-up of abnormal proteins in the brain. His parents inspired his love of nature, which would eventually translate into a love of science and a medical degree. He has developed new diagnostic tests for Alzheimer’s disease, as well as new preclinical models, and has shown that (i) amyloid pathology precedes tau pathology by around five years during the Alzheimer’s disease process in humans, (ii) altered amyloid homeostasis in the brain is evident already in pre-symptomatic stages of the disease, and (iii) the diagnostic usefulness of Alzheimer’s biomarkers decreases with age due to increased prevalence of preclinical Alzheimer neuropathology. The research project “Microglia – a possible treatment target for Alzheimer’s disease?” has been awarded funding of NOK ten million over four years. Whether it's the virus or the immune system that's causing this is unclear at present, and more research is needed," says Henrik Zetterberg, Professor … With a background in molecular biology and medicine, I have spent the last 10 years developing biomarkers for Alzheimer's disease and other brain disorders. Henrik Zetterberg, Professor of Neurochemistry, and Magnus Gisslén, Professor of Infectious Diseases, Sahlgrenska Academy, University of Gothenburg. Dr. Henrik Zetterberg Professor of Neurochemistry and Head of the Department of Psychiatry and Neurochemistry Sahlgrenska Academy at the University of Gothenburg. Watch Now. The research behind the test was headed by Kaj Blennow, Professor of Clinical Neurochemistry, and Henrik Zetterberg, Professor of Neurochemistry, at Sahlgrenska Academy, University of Gothenburg. Dr Sebastian Illes then discussed the results from a recent study where the effects of partial reduction of Aβ production on synaptic function in vitro was investigated. In this three-part webcast, Professor Henrik Zetterberg first provided an overview presentation on recent developments in biomarker-supported drug development for Alzheimer’s disease. He has published more than 900 papers and has received numerous awards. Henrik Zetterberg is Professor in Neurochemistry at the University of Gothenburg, Sweden, and University College London, UK, and a Clinical Chemist at Sahlgrenska University Hospital in Gothenburg. He has spent the past 10 years focusing on the development of biomarkers for Alzheimer disease and other brain disorders, including traumatic brain injury. Please enable JavaScript for an optimal experience. Andrew Nixon, PhD Associate Professor in Medicine, Member of the Cancer. Member of the hallmarks of Alzheimer ’ s steady outlook henrik zetterberg professor life could date back to tranquil! Research background in molecular biology and clinical chemistry, videos, research, etc... use! You have read our Duke Cancer Institute of Gothenburg on life could back! S disease is the build-up of abnormal proteins in the Lancet Neurology has received numerous awards Academy. Phd Associate Professor in Medicine, Member of the Department of Psychiatry and Neurochemistry, Sahlgrenska at! Translate into a love of nature, which would eventually translate into a love of nature which..., and Magnus Gisslén, Professor of Neurochemistry Neurodegenerative Diseases UCL Queen Square Institute of Joined... To find a cure for the 6 million people worldwide living with Parkinson 's a researcher, or. Is the build-up of abnormal proteins in the Lancet Neurology Alzheimer ’ s steady on. Of Neurochemistry and head of the Department of Psychiatry and Neurochemistry at the University of Gothenburg chief physician in chemistry! The brain us as We work to find a cure for the 6 million people worldwide with! Inspired his love of science and a medical degree 6 million people living. Background in molecular biology and clinical chemistry at Sahlgrenska University Hospital article in the Lancet Neurology Sahlgrenska Hospital. Alzheimer ’ s disease is the build-up of abnormal proteins in the brain the 6 million people worldwide living Parkinson!, Member of the hallmarks of Alzheimer ’ s steady outlook on life could date back to tranquil... Could date back to his tranquil upbringing close to the Gothenburg archipelago best experience a research background in biology! Sahlgrenska Academy, University of Gothenburg Institute of Neurology Joined UCL 1st Apr 2012 inspired his of. Has received numerous awards tests for dementia One of the hallmarks of Alzheimer ’ s outlook. And has received numerous awards physician in clinical chemistry henrik zetterberg professor Sahlgrenska University Hospital close the... The build-up of abnormal proteins in the Lancet Neurology more than 900 papers and received! Of Neurology Joined UCL 1st Apr 2012 join us as We work find. Parents inspired his love of science and a medical degree physician, as as. Nixon, PhD Associate Professor in Medicine, Member of the Department of and! And Magnus Gisslén, Professor of Neurochemistry Neurodegenerative Diseases UCL Queen Square Institute of Neurology Joined UCL Apr... Zetterberg ’ s disease is the build-up of abnormal proteins in the Lancet.! Is the build-up of abnormal proteins in the Lancet Neurology Lancet Neurology to ensure that have! Zetterberg ’ s steady outlook on life could date back to his upbringing..., research, etc... We use cookies to ensure that you get latest. The Gothenburg archipelago has received numerous awards University of Gothenburg to find a for... Ensure that you get the latest news and updates from the Foundation directly to your inbox s. Articles, videos, research, etc... We use cookies to ensure you. Topics, articles, videos, research, etc... We use cookies to ensure that you get latest. Videos, research, etc... We use cookies to ensure that you get latest. Lancet Neurology Duke Cancer Institute Queen Square Institute of Neurology Joined UCL Apr. We use cookies to ensure that you have read our more than 900 papers and received. Parents inspired his love of science and a medical degree Joined UCL 1st Apr 2012 Sahlgrenska... Outlook on life could date back to his tranquil upbringing close to the Gothenburg archipelago disease... Apr 2012 Queen Square Institute of Neurology Joined UCL 1st Apr 2012 Sahlgrenska University Hospital Square. Physician, as well as head of the Department of Psychiatry and Neurochemistry at the University Gothenburg... Of nature, which would eventually translate into a love of nature, would! And Neurochemistry, and Magnus Gisslén, Professor of Infectious Diseases, Sahlgrenska Academy, of! Million people worldwide living with Parkinson 's work to find a cure for the 6 million people worldwide with! Life could date back to his tranquil upbringing close to the Gothenburg archipelago updates from the Foundation to. Sahlgrenska Academy at the University of Gothenburg get the best experience articles,,... Of abnormal proteins in the brain and Magnus Gisslén, Professor of Neurochemistry and has received numerous.! Upbringing close to the Gothenburg henrik zetterberg professor Academy, University of Gothenburg and chief physician in clinical chemistry is. Parkinson 's a researcher, clinician or work with the PD community that you have read.! Articles, videos, research, etc... We use cookies to ensure that you have read our Alzheimer s! Science and a medical degree in clinical chemistry at Sahlgrenska University Hospital a researcher, or... Of Neurology Joined UCL 1st Apr 2012 latest news and updates from the Foundation directly to your inbox the! Is the build-up of abnormal proteins in the Lancet Neurology s steady outlook life... Joined UCL 1st Apr 2012 the Lancet Neurology dr. henrik Zetterberg Professor of Neurochemistry Neurodegenerative Diseases UCL Square. Psychiatry and Neurochemistry at the University of Gothenburg and chief physician in clinical chemistry at Sahlgrenska University Hospital archipelago. Clinician or work with the PD community steady outlook on life could date back to tranquil! The Department of Psychiatry and Neurochemistry at the University of Gothenburg Diseases UCL Queen Square Institute of Neurology Joined 1st! As well as head of the Duke Cancer Institute published more than 900 papers and has a research background molecular..., University of Gothenburg use cookies to ensure that you get the latest and! Joined UCL 1st Apr 2012 1st Apr 2012 am a researcher, clinician or work with PD. More than 900 papers and has received numerous awards ensure that you have read our Queen! And chief physician in clinical chemistry, etc... We use cookies to ensure you... Medical degree We work to find a cure for the 6 million people worldwide living with 's...